MeSH tree: N04.761.559.590
Medications are available and delivered in various forms, including liquids, pills, injections, IV drips, inhalants, and suppositories, to name a few. But what makes one option, otherwise known as a delivery system, better ...
May 5, 2026
0
4
Leveraging AI capabilities combined with genetic data led St. Jude Children's Research Hospital investigators to predict new cancer drug targets that carry a limited risk of side effects. For their study, published in Science ...
Apr 30, 2026
0
6
Independent, academic clinical cancer trials are essential to improving patient outcomes, reducing inequalities in care, and strengthening health care systems worldwide, according to a new initiative published in The Lancet ...
Apr 28, 2026
0
6
An international group of experts led by the Comprehensive Cancer Center (CCC) at MedUni Vienna and University Hospital Vienna has established endpoints for clinical trials in patients with cancer and isolated metastases. ...
Apr 28, 2026
0
5
The expanding use of robotic technology in lung transplantation came under scrutiny at the 46th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), held from 22–25 ...
Apr 25, 2026
0
3
Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a troubling mix of symptoms comprising extreme fatigue, chronic sinusitis, and appetite changes including ...
Apr 23, 2026
0
4
Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By identifying patients ...
Apr 22, 2026
0
1
At the International Society for Heart and Lung Transplantation (ISHLT) 46th Annual Meeting and Scientific Sessions, held from 22–25 April at the Metro Toronto Convention Center in Toronto, ON, Canada, transplant specialists ...
Apr 22, 2026
0
7
Cultures of silence among health care professionals remain a significant threat to patients and health care innovation, according to results from a national survey of more than 3,500 clinicians and health care administrators.
Apr 21, 2026
0
5
Late-breaking results from the Phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate noninferiority to paclitaxel/carboplatin followed by letrozole (PC/L) for progression-free survival (PFS) ...
Apr 13, 2026
0
3
